FSD Pharma is targeting all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.

FSD is a licensed producer of cannabis under the Cannabis Act. The Company received its cultivation license on October 13, 2017 under the Medical Purposes Regulations (ACMPR). An amendment to the licence, effective November 8, 2018, allows the Company to sell cannabis to other licensed producers.

FSD is a science driven company with a mission to leverage the largest hydroponic indoor cannabis facility in the world to research and develop life-saving medicines based on cannabinoid science.

FSD is planning for a stage-phased development at its primary location in Cobourg, Ontario. Currently, the Company has 25,000 square feet of grow space available. Once completed, the facility is expected to have 3,800,000 sq. ft. of cultivation and related ancillary businesses.